USP 61

Microbial Enumeration Test

Hassle-free testing experience

Need to get a product tested? No worries! To and fro logistics are on us; we collect your products, test them and, deliver them back to you.

Related tests for you

Bacterial Endotoxin Testing

Sterility Testing of Pharmaceutical Products

Ensuring Safety in Non-Sterile Medical Products
Non-Sterile Product Test For Specified Microorganisms
Antimicrobial Effectiveness Test

Quick understanding of the test

USP 61 - Microbial Enumeration Test

USP 61, also known as the microbial enumeration test, is a standardized method used to quantify mesophilic bacteria and fungi that may grow under aerobic conditions in non-sterile products.
Applicable to pharmaceuticals, cosmetics, personal care products, food, medical devices and more.

Turnaround Time

Testing typically takes 5–6 days.

Results

The number of bacterial or fungal colonies formed on the plates is counted and expressed as Colony-Forming Units (CFU) for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC).

Passing criteria

Do you have a product that needs testing?

Get a quote from our experts today!

Abstract

The United States Pharmacopeia (USP) 61 Microbial Enumeration Test is a quality test to check the presence and quantity of micro-organisms in non-sterile products including pharmaceuticals, cosmetics and in raw materials. USP 61 is also referred to as the ‘Microbial bioburden test’, ‘Microbial Limits Test’ or ‘Microbial enumeration test.’ The test is a standard method used to assess microbial load with potential risks to ensure conformity with regulations.

The microbial enumeration test determines total aerobic microbial count (TAMC) and total yeast mold count (TYMC) in the test sample.

Importance of USP 61 Microbial Enumeration Test

Microbial enumeration tests are highly essential for pharmaceuticals and cosmetics products that come into contact with the human body. Excessive number of microbes in these products can lead to infections or spoilage and pose various health risks. Therefore, periodic testing of these products keeps microbial contamination under control, significantly reducing the risk of infections from using contaminated products. Testing also ensures that the products comply with the necessary regulatory requirements, hence, reducing possible legal penalties from the sale of contaminated products.
USP 61 - Microbial Enumeration Test

Test Requirements for USP 61 Testing

The test requirements for microbial enumeration test are:

  1. A 1:10 dilution of the sample must be prepared using suitable buffers.
  2. No more than 100 CFU of microbial strain must be added to the sample, ensuring inoculation volume is less than 1%.
  3. Media should be verified to support microbial growth using growth promotion tests.
  4. If the sample shows antimicrobial activity, antimicrobial agents must be neutralized with neutralizing agents to avoid interference with microbial counts.
  5. Appropriate test methods must be used to test the sample (membrane filtration or plate count method). The choice of method depends on the nature of the product and the required microbial limit.
  6. Bacterial samples should be incubated at 30–35°C whereas fungal samples should be incubated at 20–25°C.
  7. Negative controls should be carried out to ensure that there is no external contamination.

Products tested at MIS using USP 61 Testing

The standard applies to nonsterile pharmaceutical products, cosmetics, nutraceuticals, and certain medical devices. The most commonly tested products include oral drugs, topical creams, lotions, and raw materials, among others.

USP 61 Microbial Enumeration Test Method Explained

USP  61 outlines three commonly accepted methods for estimating microbial counts in non-sterile products. The method used depends on the sample type, physical and chemical composition of the product, and expected microbial load.

1. Membrane Filtration Method

  • The product is diluted using sterile buffered diluent or neutralizing solution (as necessary). 
  • A suitable quantity of the sample is filtered through the sterile membrane filter under aseptic conditions. 
  • The membrane with sterile diluent is rinsed to remove product residues. 
  • The filter membrane is placed on Soybean–Casein Digest Agar for Total Aerobic Microbial Count (TAMC) and on Sabouraud Dextrose Agar for Total Combined Yeast and Mold Count (TYMC). 
  • The plates are incubated under controlled test conditions (Soybean– Casein Digest Agar plates: 30–35°C for 3–5 days and Sabouraud Dextrose Agar plates: 20–25°C for 5–7 days).
  • After incubation, colonies on each plate are counted and expressed as CFU per volume or weight of the product.

2. Pour-Plate Method

  • Serial dilutions of the product are performed using sterile diluent.
  • 1 mL of each dilution is transferred into separate sterile Petri dishes. 15–20 mL of molten agar is added and swirled to ensure proper mixing. The plates are allowed to solidify.
  • The plates are incubated under controlled test conditions (same as membrane filtration method).
  • Plates with 30–300 colonies are selected and the microbial count is calculated and expressed as CFU/g or mL.

3. Most Probable Number (MPN) Method

  • Serial dilutions of the product are prepared using sterile diluent.
  • From each level of dilution, 3 aliquots of 1ml are used to inoculate three tubes of Soybean–Casein Digest Broth media. 
  • All test tubes are incubated at 30–35°C for not more than 3 days.
  • The number of positive tubes in each dilution set is recorded.
  • The most probable number of microorganisms per gram or mL of sample is estimated using an MPN table.

Suitable Method for USP 61 Microbial Enumeration Test

Suitability testing checks if the chosen microbial enumeration method will recover microorganisms in the presence of the test product. This is done by testing if the product being examined has any inhibitory activity against the microorganisms being recovered. Should the product possess antimicrobial activity, inactivators or neutralizers are added to eliminate or neutralize such effects.

Interpretation of USP 61 Microbial Enumeration Test Results

  1. Total Aerobic Microbial Count (TAMC) is expressed as CFU which is equivalent to the number of colonies on Soybean-Casein Digest Agar. In addition, the presence of fungal colonies on the Soybean-Casein Digest Agar shall also be counted in the TAMC.

  2. Total Yeast and Mold Count (TYMC) is equivalent to the number of colonies (CFU) found on the Sabouraud Dextrose Agar. Any colonies of bacteria count toward TYMC.

Acceptable guidelines for USP 61 Microbial Enumeration Test

The acceptable limits of microbial count as per USP standards are:

  • For products designed for infants, used under the eye area or mucous membranes: <200 CFU/ml or 102 CFU/ml
  • For other products: <2000 CFU/ml or 103 CFU/ml

Applications of USP 61 Microbial Enumeration Test

Pharmaceuticals

  • Ensuring the microbiological quality of non-sterile pharmaceutical products, including tablets, capsules, syrups, and topical medications.
  • Testing raw materials and excipients used in drug formulation to ensure they meet microbiological standards.

Cosmetics

  • Evaluating the microbial load in cosmetic products including creams, lotions, shampoos, and makeup.
  • Testing for microbial contamination in raw materials used in cosmetic formulations.

Personal care products

  • Assessing the microbiological quality of personal care products such as soaps, deodorants, and toothpaste.
  • Ensuring that products intended for personal hygiene do not contain harmful levels of microorganisms.

Food and beverages

  • Testing non-sterile food products and beverages for microbial contamination to ensure they are safe for consumption.
  • Monitoring the microbiological quality of ingredients and packaging materials used in the food industry.

Nutritional supplements

  • Ensuring the microbiological safety of dietary supplements including vitamins, minerals, and herbal products.
  • Testing raw materials and finished products for microbial contamination.

Medical devices

  • Evaluating the bioburden on non-sterile medical devices and components prior to sterilization.
  • Ensuring that medical devices meet microbiological quality standards to prevent infections in patients.

Biopharmaceuticals

  • Testing biologically derived products such as vaccines, cell cultures, and tissue engineering products for microbial contamination.
  • Ensuring the microbiological quality of biopharmaceutical raw materials and intermediates.

Veterinary products

  • Assessing the microbiological quality of nonsterile veterinary products including medications, supplements, and care products for animals.
  • Ensuring that veterinary products are free from harmful microbial contamination.

Research and development

  • Conducting microbiological testing during the development of new pharmaceutical and cosmetic products.
  • Evaluating the effectiveness of preservatives and antimicrobial agents in product formulations.

At MIS, we offer precise and compliant USP  61 testing services. We also perform USP 60 and USP 62 tests to assess the growth of specific microorganisms in non-sterile products. Our experts understand the client’s needs and expectations first and take complete responsibility to provide reliable and accurate results. 

Contact our experts now to discuss your Microbial enumeration test requirements and other related antimicrobial tests.

Frequently Asked Questions

DR. Martinoz Scholtz

MIS Labs
1. How are samples prepared for the microbial limits test?

Samples are prepared by aseptic dilution in a sterile diluent to provide low-concentration levels for the plating. This is necessary to avoid errors in counting microbial colonies.

2. What happens if a product fails the microbial limits test?

In case a product fails the test, an investigation is done to identify the source of contamination. The product can either be reformulated or rejected depending on the results obtained.

3. How does the microbial enumeration test ensure product safety for consumers?

The test ensures that the microbial levels are within the acceptable limits in non-sterile products thus reducing the possible adverse health effects like infections and allergic reactions.

4. How can you minimize contamination during the microbial enumeration test process?

A controlled environment, working with sterile equipment, exercising good laboratory practices, and maintaining strict aseptic conditions can help reduce the possibility of contamination.

5. What are the potential interferences that can affect the test results?

Sample ingredients that inhibit microbial growth, such as preservatives or poor sample preparation techniques, can give false positives for a microorganism’s presence.

6. What is the difference between USP 61 and USP 62?

USP 61 is for the determination of the presence of total viable aerobic bacteria and fungi. USP 62 deals with the detection of specific microbiological agents that may be pathogenic.

7. What is the USP 61 update?

The recent USP <61> update, approved by the Pharmacopeial Discussion Group (PDG), refines the membrane filtration method suitability criteria. It now requires that the count of each test organism must not differ by more than a factor of 2 from the control value.

8. What is the most current version of the USP?

The most current version of the USP is USP–NF 2024, Issue 1 and is available on the official USP website.

Meet the best of the blend of
R&D, Efficacy Testing,
Innovation and Passionate
Experts at MIS.

Send us your sample and experience High quality Swiss standards, Industry leading turnaround times, and affordable prices.

    Explore More